PRAX is currently covered by 3 analysts with average potential upside of $15.62 (237.33%) backed by 5 price targets and 10 ratings. Documented since 11-Nov-2020. Analyst's average stock valuation to be materialised ratio is 16.67% with an average time for price targets to be met of 6.33 days.
Most recent stock forecast was given by DOUGLAS TSAO from HCWAINWRIGHT on 06-Mar-2023.
Highest price target for PRAX is 22, Lowest price target is 1, average price target is 11.5.
Currently, out of the existing stock ratings of PRAX - 6 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
16
$15.18 (1851.22%)
16
21 days ago
0/3 (0%)
$12.64 (618.31%)
Buy
45
$44.18 (5387.80%)
61
1 years 4 months 23 days ago
2/4 (50%)
$11.73 (40.77%)
19
Buy
65
$63 (3150.00%)
2 years 10 days ago
0/1 (0%)
$22.49 (52.91%)
What is PRAX(Praxis Precision Medicines Inc.) average time for price targets to be met?
Which analyst has the current highest performing score on PRAX(Praxis Precision Medicines Inc.) with a proven track record?